Current treatment for acute viral bronchiolitis in infants

@article{MartinnTorres2003CurrentTF,
  title={Current treatment for acute viral bronchiolitis in infants},
  author={F. Martin{\'o}n-Torres},
  journal={Expert Opinion on Pharmacotherapy},
  year={2003},
  volume={4},
  pages={1355 - 1371}
}
This paper provides an update and critical review of available data on the treatment of acute viral bronchiolitis in previously healthy infants, with special focus on new or promising therapies. The main potential benefits of medical assistance in these patients reside in the careful monitoring of their clinical status, the maintenance of adequate hydration and oxygenation, the preservation of the airway opened and cleared of secretions and the option to perform parental education. There is no… Expand
Clinical effects of heliox administration for acute bronchiolitis in young infants.
TLDR
In young infants, even those born prematurely, heliox breathing induced a rapid reduction in accessory muscles use and expiratory wheezing and further studies are needed to confirm the decreased respiratory muscle work of breathing during heliox inhalation in this population. Expand
Clinical effects of heliox administration for acute bronchiolitis in young infants.
TLDR
In young infants, even those born prematurely, heliox breathing induced a rapid reduction in accessory muscles use and expiratory wheezing, and further studies are needed to confirm the decreased respiratory muscle work of breathing during heliox inhalation in this population. Expand
Respiratory care of bronchiolitis patients: a proving ground for process improvement.
This issue of RESPIRATORY CARE reports a study from Conway et al at Children’s Hospital Cincinnati in which efforts were made to standardize the care of infants and children suffering viralExpand
High-flow nasal cannula therapy for infants with bronchiolitis.
TLDR
The current evidence is of low quality, from one small study with uncertainty about the estimates of effect and an unclear risk of performance and detection bias, and the included study provides some indication that HFNC therapy is feasible and well tolerated. Expand
Nasal continuous positive airway pressure with heliox in infants with acute bronchiolitis.
TLDR
In conclusion, Hx-nCPAP improved the clinical score, decreased the tachypnea and enhanced the CO2 elimination of infants with refractory acute bronchiolitis within 1h of administration, in a safe and non-invasive manner. Expand
Nasal Continuous Positive Airway Pressure With Heliox Versus Air Oxygen in Infants With Acute Bronchiolitis: A Crossover Study
TLDR
Nasal continuous positive airway pressure improves the clinical score and the CO2 elimination of infants with refractory bronchiolitis and is significantly enhanced when nasal continuous positiveAirway pressure is combined with heliox instead of air oxygen. Expand
Ventilación no invasiva con heliox en un lactante con síndrome de dificultad respiratoria aguda
TLDR
The case of a 4-month-old infant with acute respiratory insufficiency due to severe acute respiratory distress syndrome secondary to respiratory syncytial virus infection is described, successfully treated with nasal continuous positive airway pressure and heliox (Hx-nCPAP). Expand
Efectos de la ventilación mecánica con heliox en niños y adolescentes con patología bronquial obstructiva
TLDR
La ventilacion mecanica con Heliox en ninos con patologia bronquial obstructiva parece ser que reduce de manera significativa la resistencia de the via aerea, con tendencia al descenso of the PetC02. Expand
Akut Bronşiyolit Tedavisinde Nebülize Adrenalin, Salbutamol ve İpratropiyumBromür Tedavi Etkinliğinin Araştırılması
TLDR
Or ta şid det li bron şi o lit li has ta la rın te da vi sin de kli nik skor, so lu num sa yı sı ve kalp te pe atı mı oran de ğer le ri ba mın dan an lam lı bir fark lı lık bu lun ma dı (p>0.05). Expand

References

SHOWING 1-10 OF 250 REFERENCES
[Acute bronchiolitis: evaluation of evidence-based therapy].
TLDR
It is concluded that the only justifiable therapeutic interventions in these patients are supportive treatment, nebulized epinephrine and mechanical ventilation, and no evidence supports the routine use of corticosteroids, beta-adrenergic drugs, antibiotics, immunoglobulins, interferon, vitamin A or ribavirin. Expand
Dexamethasone and bronchiolitis: a new look at an old therapy?
TLDR
A physician treating a child with bronchiolitis and respiratory compromise who also has underlying airway disease should strongly consider corticosteroid therapy regardless of the questionable efficacy of Corticosteroids in previously well children with viral-associated wheezing. Expand
Theophylline therapy in bronchiolitis. A retrospective study.
TLDR
The results suggest that theophylline and steroid therapies had not beneficial effects on the resolution of acute bronchiolitis or wheezing in the majority of infants and small children. Expand
Bronchiolitis. Origins and optimal management.
TLDR
The role of the antiviral agent ribavirin in the improved outcome, if any, is unclear and the only effective preventive intervention currently available is strict adherence to measures designed to prevent nosocomial infection. Expand
Corticosteroid treatment in bronchiolitis. A controlled, collaborative study in 297 infants and children.
TLDR
The investigators designed a common protocol and standard case report forms for use at the five collaborating centers that permitted an evaluation of the effects of the corticosteroid in bronchiolitis and provided further insight into the natural history of the disease. Expand
Dexamethasone in bronchiolitis: a randomised controlled trial
TLDR
The findings do not support the use of dexamethasone in the treatment of bronchiolitis in infants. Expand
Treatment of respiratory syncytial virus infections in children.
TLDR
Until an efficient vaccine is brought to clinical use, the best way to limit nosocomial spread of infections is to use cohort nursing and gowns. Expand
Efficacy of corticosteroids in acute bronchiolitis: Short‐term and long‐term follow‐up
TLDR
The aim of this study was to examine the short‐term and long‐term efficacy of oral corticosteroid therapy when added to β2‐agonists in infants with mild to moderate bronchiolitis. Expand
[Acute bronchiolitis: fundamentals of a rational protocol].
TLDR
The use of inhaled adrenaline in the treatment of moderate-to-severe bronchiolitis in hospitalized infants, as well as oxygen and fluid therapy as support measures, are recommended. Expand
Respiratory syncytial virus bronchiolitis: supportive care and therapies designed to overcome airway obstruction
  • H. Panitch
  • Medicine
  • The Pediatric infectious disease journal
  • 2003
TLDR
Oxygen administration and judicious fluid replacement are the only interventions proved to be of reliable benefit to infants with bronchiolitis, newer studies support a role for adjunctive therapies aimed at relieving airway obstruction. Expand
...
1
2
3
4
5
...